go back to the top ten menu

Bionicare is a new, non-invasive therapy (FDA approved) for the treatment of osteoarthritis of the knee and rheumatoid arthritis of the hand. A wrap is placed on the affected site and attached to a small battery-powered transmitter for six to eight hours every day. The transmitter sends an electrical signal to the hyaline cartilage cells in your joint. This signal has been shown in animals to stimulate the cells to regenerate the cartilage and reduce the inflammatory enzymes that cause pain and stiffness in joints. Although cartilage growth has not yet been proven in humans, Bionicare has been shown to reduce pain and associated symptoms as well as produce overall improvement of the osteo-arthritic knee1 by physicians’ global evaluation. A long-term study has shown that treatment with Bionicare can delay the need for total joint arthroplasty in a majority of patients treated for an average of one year.²

Bionicare is based on technology that has been well established over the past 30 years in stimulating bone cells to produce bone. There have been no adverse effects associated with Bionicare, except for a few patients who developed a rash from the gel.

Positive results probably require treatment for six months or more. Although it is possible to walk around wearing the wrap during the day, most patients apply the wrap at night.

Insurance payment for Bionicare depends on your insurance company, so a request will need to be submitted to the company if you want to be reimbursed. For self-pay patients, and for those who have insurance issues, the company offers a payment plan to help make the product affordable.

Patient Education information provided by Biomet, Inc. - Advanced Science for Real Living™